104 related articles for article (PubMed ID: 26824902)
21. Oral Human Papillomavirus in Women With High-Grade Cervical Intraepithelial Neoplasia.
Woelber L; Breuer J; Meyer T; Vettorazzi E; Prieske K; Bohlmann I; Busch CJ; Teudt I; Brummer O; Mueller V; Schmalfeldt B; Grimm D
J Low Genit Tract Dis; 2017 Jul; 21(3):177-183. PubMed ID: 28481782
[TBL] [Abstract][Full Text] [Related]
22. Clearance of cervical human papillomavirus infection by topical application of curcumin and curcumin containing polyherbal cream: a phase II randomized controlled study.
Basu P; Dutta S; Begum R; Mittal S; Dutta PD; Bharti AC; Panda CK; Biswas J; Dey B; Talwar GP; Das BC
Asian Pac J Cancer Prev; 2013; 14(10):5753-9. PubMed ID: 24289574
[TBL] [Abstract][Full Text] [Related]
23. A randomized, double-blind, placebo-controlled trial of 5-fluorouracil for the treatment of cervicovaginal human papillomavirus.
Holmes MM; Weaver SH; Vermillion ST
Infect Dis Obstet Gynecol; 1999; 7(4):186-9. PubMed ID: 10449266
[TBL] [Abstract][Full Text] [Related]
24. An Alternative Treatment for Vaginal Cuff Wart: a Case Report.
Psomiadou V; Iavazzo C; Douligeris A; Fotiou A; Prodromidou A; Blontzos N; Karavioti E; Vorgias G
Acta Medica (Hradec Kralove); 2020; 63(1):49-51. PubMed ID: 32422116
[TBL] [Abstract][Full Text] [Related]
25. Impact of antiviral AV2 in the topical treatment of HPV-associated lesions of the cervix: Results of a phase III randomized placebo-controlled trial.
Baleka Mutombo A; Tozin R; Kanyiki H; Van Geertruyden JP; Jacquemyn Y
Contemp Clin Trials Commun; 2019 Sep; 15():100377. PubMed ID: 31193477
[TBL] [Abstract][Full Text] [Related]
26. Effect of intravaginal practices on the vaginal and cervical mucosa of Zimbabwean women.
van de Wijgert JH; Chirenje ZM; Iliff V; Mbizvo MT; Mason PR; Gwanzura L; Shiboski S; Padian NS
J Acquir Immune Defic Syndr; 2000 May; 24(1):62-7. PubMed ID: 10877497
[TBL] [Abstract][Full Text] [Related]
27. A phase I randomized placebo controlled trial of the safety of 3% SPL7013 Gel (VivaGel®) in healthy young women administered twice daily for 14 days.
Cohen CR; Brown J; Moscicki AB; Bukusi EA; Paull JR; Price CF; Shiboski S
PLoS One; 2011 Jan; 6(1):e16258. PubMed ID: 21311578
[TBL] [Abstract][Full Text] [Related]
28. Safety and Acceptability of Thermal Ablation for Treatment of Human Papillomavirus Among Women Living With HIV in Western Kenya.
Mungo C; Osongo CO; Ambaka J; Randa MA; Omoto J; Cohen CR; Huchko M
JCO Glob Oncol; 2020 Jul; 6():1024-1033. PubMed ID: 32634066
[TBL] [Abstract][Full Text] [Related]
29. A preliminary study for the treatment of cervical colposcopic lesions with the biological compound AV2.
Martinez G; Mutombo BA; Fernandez V; Van Geertruyden JP; Jacquemyn Y
Eur J Gynaecol Oncol; 2017; 38(3):342-345. PubMed ID: 29693869
[TBL] [Abstract][Full Text] [Related]
30. Machine learning prediction of antiviral-HPV protein interactions for anti-HPV pharmacotherapy.
Lin HH; Zhang QR; Kong X; Zhang L; Zhang Y; Tang Y; Xu H
Sci Rep; 2021 Dec; 11(1):24367. PubMed ID: 34934067
[TBL] [Abstract][Full Text] [Related]
31. Empirical tuberculosis therapy versus isoniazid in adult outpatients with advanced HIV initiating antiretroviral therapy (REMEMBER): a multicountry open-label randomised controlled trial.
Hosseinipour MC; Bisson GP; Miyahara S; Sun X; Moses A; Riviere C; Kirui FK; Badal-Faesen S; Lagat D; Nyirenda M; Naidoo K; Hakim J; Mugyenyi P; Henostroza G; Leger PD; Lama JR; Mohapi L; Alave J; Mave V; Veloso VG; Pillay S; Kumarasamy N; Bao J; Hogg E; Jones L; Zolopa A; Kumwenda J; Gupta A;
Lancet; 2016 Mar; 387(10024):1198-209. PubMed ID: 27025337
[TBL] [Abstract][Full Text] [Related]
32. Low Vitamin-D Levels Combined with PKP3-SIGIRR-TMEM16J Host Variants Is Associated with Tuberculosis and Death in HIV-Infected and -Exposed Infants.
Gupta A; Montepiedra G; Gupte A; Zeldow B; Jubulis J; Detrick B; Violari A; Madhi S; Bobat R; Cotton M; Mitchell C; Spector S;
PLoS One; 2016; 11(2):e0148649. PubMed ID: 26872154
[TBL] [Abstract][Full Text] [Related]
33. Community perceptions of mass screening and treatment for malaria in Siaya County, western Kenya.
Shuford K; Were F; Awino N; Samuels A; Ouma P; Kariuki S; Desai M; Allen DR
Malar J; 2016 Feb; 15():71. PubMed ID: 26852227
[TBL] [Abstract][Full Text] [Related]
34. Effect of Low Dose Oral Vitamin-D and Calcium Replacement in HIV Patients.
Das S; Bopitya S; Chowdhury AR; Das A; Taha H
Recent Pat Antiinfect Drug Discov; 2016; 11(1):59-67. PubMed ID: 26844688
[TBL] [Abstract][Full Text] [Related]
35. HIV-1 Protease Inhibitors Slow HPV16-Driven Cell Proliferation through Targeted Depletion of Viral E6 and E7 Oncoproteins.
Park S; Auyeung A; Lee DL; Lambert PF; Carchman EH; Sherer NM
Cancers (Basel); 2021 Feb; 13(5):. PubMed ID: 33668328
[TBL] [Abstract][Full Text] [Related]
36. Role of the epithelium in human papillomavirus and human immunodeficiency virus infections in the female genital tract.
Sibeko S; Sanderson M; Moyo S; Botha MH
Front Reprod Health; 2024; 6():1408198. PubMed ID: 38764554
[TBL] [Abstract][Full Text] [Related]
37. Perceived acceptability of self-administered topical therapy for cervical precancer treatment among women undergoing cervical cancer screening in Kenya.
Mungo C; Ellis GK; Rop M; Zou Y; Omoto J; Rahangdale L
medRxiv; 2024 Mar; ():. PubMed ID: 38585806
[TBL] [Abstract][Full Text] [Related]
38. "There is nothing that can prevent me from supporting her:" men's perspectives on their involvement and support of women's use of topical therapy for cervical precancer treatment in Kenya.
Mungo C; Adewumi K; Adoyo E; Zulu G; Goraya SK; Ogollah C; Omoto J; Ferrari RM; Rahangdale L
Front Oncol; 2024; 14():1360337. PubMed ID: 38532929
[TBL] [Abstract][Full Text] [Related]
39. "There is nothing that can prevent me from supporting her:" Men's perspectives on their involvement and support of women's use of topical therapy for cervical precancer treatment in Kenya.
Mungo C; Adewumi K; Adoyo E; Zulu G; Goraya SK; Ogollah C; Omoto J; Ferrari RM; Rahangdale L
medRxiv; 2023 Dec; ():. PubMed ID: 38234805
[TBL] [Abstract][Full Text] [Related]
40. Topical Protease Inhibitor Decreases Anal Carcinogenesis in a Transgenic Mouse Model of HPV Anal Disease.
Gunder LC; Johnson HR; Yao E; Moyer TH; Green HA; Sherer N; Zhang W; Carchman EH
Viruses; 2023 Apr; 15(4):. PubMed ID: 37112993
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
